Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06117449
Other study ID # ESITT2DP
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date April 1, 2024
Est. completion date May 1, 2025

Study information

Verified date March 2024
Source Assiut University
Contact Esraa Ashraf
Phone 01154727599
Email esraaelshenawy8497@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Diabetes mellitus is an endocrine disorder with heterogeneous etiologies, which is characterized by raised levels of glucose in a person's blood and disturbances of macromolecules such as carbohydrate, fat, and protein metabolism resulting from defects in insulin secretion, insulin action, or both. A lack of insulin, or the inability of cells to respond to it, leads to high levels of blood glucose (hyperglycemia), which is the clinical indicator of diabetes. Type 1 DM is characterized by insulin deficiency and a tendency to develop diabetic ketoacidosis, whereas type 2 DM is characterized by variable degrees of insulin resistance, impaired insulin secretion, and excessive hepatic glucose produc Tion. Diabetes is one of the most rapidly increasing chronic diseases and an important public health problem all over the world. The global burden of diabetes is rising dramatically worldwide. Type 2 diabetes is the most common type of diabetes, accounting for around 90% of all diabetes worldwide (IDF). The prevalence of type 2 diabetes is high and rising across all regions. This rise is driven by increasing life expectancy, economic development, and increasing urbanization leading to more sedentary lifestyles and greater consumption of unhealthy foods linked with obesity. Type 2 diabetes prevalence has increased in Egypt during the past few years. Egypt is one of the top ten nations with the greatest proportion of adults with diabetes, according to the International Diabetes Federation. In Egypt, the prevalence of diabetes was projected to be 9.6 million, with type 2 diabetes making up the bulk of cases .


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date May 1, 2025
Est. primary completion date April 1, 2025
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: -Patients with type 2 diabetes mellitus aged =18 years. - Patients going on insulin therapy versus patients going on oral antidiabetic drugs. - patients included if they met the following Criteria: - previous diagnosis of diabetes mellitus or on medical therapy of DM. - no prescription fills for a basal insulin containing product in the 1-year pre index date period; and no prescription fills for bolus insulin or mixed insulin products on index date or in the 1-year pre-index date periods. Exclusion Criteria: - Patients had type 1 diabetes mellitus. - Pregnant patients. - Incapable of completing the study questionnaires. - were pregnant at any time during the pre-or post-index periods; or - were diagnosed with any other type of diabetes during the study period, including, gestational diabetes , secondary diabetes , or other abnormal glu-cose conditions . - Patients who were con-comitantly participating in another trial or receiving insulin treatment for reasons other than T2DM.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

References & Publications (3)

Elsner RH. California bureaucrats propose control of excess physicians. Fed Bull. 1979 May;66(5):140-1. No abstract available. — View Citation

Ishii H, Terauchi Y, Jinnouchi H, Taketsuna M, Takeuchi M, Imaoka T. Effects of insulin changes on quality of life and glycemic control in Japanese patients with type 2 diabetes mellitus: The insulin-changing study intending to gain patients' insights into insulin treatment with patient-reported health outcomes in actual clinical treatments (INSIGHTs) study. J Diabetes Investig. 2013 Nov 27;4(6):560-70. doi: 10.1111/jdi.12086. Epub 2013 Apr 30. — View Citation

Witek TJ Jr. The nose as a target for adverse effects from the environment: applying advances in nasal physiologic measurements and mechanisms. Am J Ind Med. 1993 Nov;24(5):649-57. doi: 10.1002/ajim.4700240512. No abstract available. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary blood glucose level comparison of blood glucose level on patients who going on insulin therapy with patient going on oral antidiabetic baseline
Primary HbA1C level comparison of HbA1C level on patients who going on insulin therapy with patient going on oral antidiabetic baseline
See also
  Status Clinical Trial Phase
Recruiting NCT04940962 - Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion N/A
Completed NCT05359341 - Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients? N/A
Recruiting NCT04700813 - Research Study for Rare Pathogenic Mutations Causing Type 2 Diabetes and Complications
Completed NCT05413330 - Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes. Phase 2/Phase 3
Recruiting NCT04927377 - Accessible and Inclusive Diabetes Telecoaching Self-Management Program N/A
Completed NCT05585268 - Electronic Decision Support for Deprescribing in Patients on Hemodialysis N/A
Active, not recruiting NCT05088616 - Native American Diabetes Project N/A
Not yet recruiting NCT03273738 - Vascular and Metabolic Changes in Postmenopausal Diabetics
Active, not recruiting NCT04642911 - Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy
Withdrawn NCT04283617 - Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study N/A
Recruiting NCT04769687 - Symbiotics and Systemic Inflammation in Chronic Kidney Disease Phase 2
Withdrawn NCT06104358 - Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes Phase 2
Recruiting NCT03341793 - Impact of Changes in Muscle Secretome in the Remission of Type 2 Diabetes Mellitus Induced by Bariatric Surgery N/A
Not yet recruiting NCT06080802 - The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction Phase 2/Phase 3
Recruiting NCT04485845 - Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression Phase 4
Recruiting NCT05050500 - The Effect of Dapagliflozin on the Short-term Prognosis of Patients With Acute Myocardial Infarction Phase 4
Completed NCT04115657 - The Effect of Different Starches of Boba Pearls and Sugar Substitutes Used in Milk Tea on Glycaemia, Insulinaemia and Appetite Control (Pearl Study) N/A
Completed NCT06188572 - The Effect of Peripheral Neuropathy Symptoms on Temporomandibular Joint Functionality
Completed NCT04120844 - Effectiveness of Motivational Interviewing on Improving Care for Type 2 Diabetes Mellitus Patients in China N/A
Completed NCT05789706 - Use of a Smart-phone Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Non-insulin Dependent Diabetes Among Veterans N/A